受强制性开放获取政策约束的文章 - Tobias Bexte了解详情
无法在其他位置公开访问的文章：1 篇
Nonviral technologies can pave the way for CAR-NK cell therapy
T Bexte, LM Reindl, E Ullrich
Journal of Leukocyte Biology 114 (5), 475-486, 2023
强制性开放获取政策： German Research Foundation, Federal Ministry of Education and Research, Germany
可在其他位置公开访问的文章：6 篇
High cytotoxic efficiency of lentivirally and alpharetrovirally engineered CD19-specific chimeric antigen receptor natural killer cells against acute lymphoblastic leukemia
S Müller, T Bexte, V Gebel, F Kalensee, E Stolzenberg, J Hartmann, ...
Frontiers in immunology 10, 3123, 2020
强制性开放获取政策： German Research Foundation
CRISPR-Cas9 based gene editing of the immune checkpoint NKG2A enhances NK cell mediated cytotoxicity against multiple myeloma
T Bexte, J Alzubi, LM Reindl, P Wendel, R Schubert, ...
Oncoimmunology 11 (1), 2081415, 2022
强制性开放获取政策： German Research Foundation
Arming immune cells for battle: A brief journey through the advancements of t and nk cell immunotherapy
P Wendel, LM Reindl, T Bexte, L Künnemeyer, V Särchen, N Albinger, ...
Cancers 13 (6), 1481, 2021
强制性开放获取政策： German Research Foundation
Immunotherapy with NK cells: recent developments in gene modification open up new avenues
LM Reindl, N Albinger, T Bexte, S Müller, J Hartmann, E Ullrich
Oncoimmunology 9 (1), 1777651, 2020
强制性开放获取政策： German Research Foundation
Engineering of potent CAR NK cells using non-viral Sleeping Beauty transposition from minimalistic DNA vectors
T Bexte, L Botezatu, C Miskey, F Gierschek, A Moter, P Wendel, ...
Molecular Therapy, 2024
强制性开放获取政策： Helmholtz Association, European Commission
The RHOA Mutation G17V Does Not Lead to Increased Migration of Human Malignant T Cells but Is Associated with Matrix Remodelling
K Merk-Ahmad, J Bein, S Scharf, H Schäfer, T Bexte, E Ullrich, AG Loth, ...
Cancers 15 (12), 3226, 2023
强制性开放获取政策： German Research Foundation
出版信息和资助信息由计算机程序自动确定